Benzinga | Sep 21, 2021 06:10AM EDT

Citigroup Initiates Coverage On Cano Health with Buy Rating, Announces Price Target of $20

Citigroup analyst Ralph Giacobbe initiates coverage on Cano Health (NYSE:CANO) with a Buy rating and announces Price Target of $20.